Thomas G. Cotter
Epidemiology · 2009–2020
A researcher in the Science corpus: 2 papers; trusts 11 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 53 citations into it
- Endocrinology, Diabetes and Metabolism — 39 citations into it
- Molecular Biology — 12 citations into it
- Pathology and Forensic Medicine — 10 citations into it
Whom Thomas G. Cotter trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Guido Kroemer
- G. Lessene
- A. Letai
- H. Horvitz
- L. Galluzzi
- P. Czabotar
- Z. Younossi
- K. Yip
- C. Brenner
- P. Colman
Who trusts Thomas G. Cotter overall
Papers from Thomas G. Cotter's perspective
Ordered by how strongly the researchers Thomas G. Cotter trusts endorse each paper. Same corpus, a different order for every researcher.
- BCL-2 family antagonists for cancer therapy (Nature reviews. Drug discovery)
- miR-15 and miR-16 induce apoptosis by targeting BCL2. (Proceedings of the National Academy of Sciences of the United States of America)
- Mitochondrial membrane permeabilization in cell death. (Physiological Reviews)
- NOBEL LECTURE: Worms, Life and Death
- Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. (Cell)
- Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. (Cell)
- Diagnosing and exploiting cancer's addiction to blocks in apoptosis (Nature Reviews. Cancer)
- The TRAIL apoptotic pathway in cancer onset, progression and therapy (Nature Reviews. Cancer)
- Bcl-2 family proteins and cancer (Oncogene)
- Autophagy in the pathogenesis of disease. (Cell)
Their papers
- Apoptosis and cancer: the genesis of a research field (2009) — 807 citations
- NAFLD 2020: The State of the Disease. (2020) — 883 citations